MassimoRaimondoMD
Gastroenterology • Jacksonville, FLGastrointestinal Cancer, Pancreas Disease
Professor, Internal Medicine, Mayo Medical School
Dr. Raimondo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Summary
- Dr. Massimo Raimondo is a gastroenterologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida. He received his medical degree from University of Palermo and has been in practice 31 years. He also speaks multiple languages, including Italian. He specializes in gastrointestinal cancer and pancreas disease and is experienced in general gastroenterology, interventional gastroenterology, endoscopy, biliary tract disease, and pancreatic cancer.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1995 - 1998
Mercy Catholic Medical CenterResidency, Internal Medicine, 1992 - 1995
University of PalermoClass of 1986, MD, Magna cum Lode
Certifications & Licensure
FL State Medical License 2000 - 2025
MN State Medical License 2000 - 2020
NC State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer Start of enrollment: 2007 May 01
- PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- The Determinants of Inpatient Palliative Care Use in Patients With Pancreatic Cancer.Osayande Osagiede, Kapil Nayar, Massimo Raimondo, Vivek Kumbhari, Frank J Lukens
The American Journal of Hospice & Palliative Care. 2024-11-01 - Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study.Megan M L Engels, Calise K Berger, Douglas W Mahoney, Sanne A Hoogenboom, Dhruv Sarwal
Clinical Gastroenterology and Hepatology. 2024-10-28 - Modified Bedside Index for severity in acute pancreatitis (BISAP) score validation in the national inpatient sample database.Do Han Kim, Frank J Lukens, Donghyun Ko, Paul T Kröner, Miguel Salazar
Advances in Medical Sciences. 2023-09-01
Other
- Endoscopic ultrasound in chronic pancreatitisRaimondo M, Wallace MB
http://www.uptodate.com/contents/endoscopic-ultrasound-in-chronic-pancreatitis
UpToDate, Wolters Kluwer Health - 2012-03-01
Authored Content
- Mo1707 PROSPECTIVE OBSERVATIONAL STUDY ON OPTICAL DETECTION OF RESIDUAL COLORECTAL NEOPLASIA AFTER ENDOSCOPIC MUCOSAL RESECTION: IMPACT OF ENDOCLIP CLOSURE OF EMR SITEMay 2018
- Mo1707 PROSPECTIVE OBSERVATIONAL STUDY ON OPTICAL DETECTION OF RESIDUAL COLORECTAL NEOPLASIA AFTER ENDOSCOPIC MUCOSAL RESECTION: IMPACT OF ENDOCLIP CLOSURE OF EMR SITEMay 2018
Press Mentions
Molecular Marker from Pancreatic 'Juices' Helps Identify Pancreatic CancerMay 19th, 2013
Mayo Clinic Researchers Decode Origin of Inflammation-Driven Pancreatic CancerFebruary 12th, 2016
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
